With a market cap of $12.6 billion, Baxter International Inc. (BAX) is a global healthcare technology company that develops and manufactures essential medical products, therapies, and equipment used in hospitals, surgical centers, and home-care settings. Its portfolio includes intravenous (IV) solutions, infusion pumps, injectable pharmaceuticals, surgical equipment, smart hospital beds, and patient monitoring systems. The Deerfield, Illinois-based company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals, serving healthcare providers and patients in more than 100 countries.
The company is expected to unveil its fiscal Q3 2026 results before the market opens on Thursday, Oct. 29. Ahead of the event, analysts forecast BAX to post an adjusted EPS of $0.51, a decline of 26.1% from $0.69 in the same quarter last year. It has surpassed Wall Street's bottom-line projections in three of the past four quarters while missing on another occasion.